Navigation Links
Recent Article Reveals Medical Ghostwriting Suppressed Links Between Synthetic Hormones and Breast Cancer
Date:8/20/2009

A recent New York Times article, ''Senator Moves to Block Medical Ghostwriting,'' raises a heinous accusation, that Wyeth paid medical ghostwriters to suppress clinical evidence linking the use of synthetic hormone drugs to an increased risk of breast cancer.

Jacksonville, Fla. (Vocus) August 20, 2009 -- A recent New York Times article, ''Senator Moves to Block Medical Ghostwriting,'' raises a heinous accusation, that Wyeth paid medical ghostwriters to suppress clinical evidence linking the use of synthetic hormone drugs to an increased risk of breast cancer.

"I am gratified that the truth may finally be coming to light," said C.W.Randolph, Jr., M.D., "Even after the 2002 National Institutes of Health, Women's Health Initiative Trial (WHI) irrefutably established that synthetic hormones (such as the popularly prescribed Premarin family of products) caused the risk of breast cancer to increase 26 percent, physicians continued to prescribe these drugs putting millions of women's lives in jeopardy. Why? Because they were misled by pharmaceutical-sponsored medical studies skewing the facts."

According to Dr. Randolph, a nationally recognized medical expert in the field of natural, or Bioidentical Hormone Replacement Therapies (BHRT), this type of evidence has existed for decades.

As early as 1941, Edgar Allen, M.D., Chair of Yale Medical School Anatomy Department, published an article in the medical journal Cancer Research on the propensity of estrogen to cause cancer in animals. Since that time, the output of medical research and clinical studies continued to mount until, in 2001, representatives from the National Cancer Institute and the National Institutes of Health (NIH) voted 8-1 to add synthetic estrogen to the nation's list of cancer-causing agents.

Recent revelations that Wyeth directed DesignWrite medical ghostwriters to deliberately deemphasize the links between synthetic hormone replacement therapies and breast cancer in published medical journals are bringing experts in the field of BHRT to answer the question of the purpose for manipulating this data.

''Because there is big money at stake,'' says Genie James, M.M.Sc., Executive Director of the Natural Hormone Institute. ''Prior to the WHI findings being made public in 2002, the Premarin-family of products was a 2.2 billion dollar pipeline.''

According to an article in The New York Times, since 2002, sales for Wyeth's Premarin family of products have plummeted 50 percent, and have continued to decline over the last several years.

Research in the U.S. and around the world supports BHRT as the treatment of choice for menopausal symptoms and conditions of hormone imbalance.

"The sad reality is that when marketing gets ahead of medical science, women's lives are put at risk," says James.

About C.W. Randolph, Jr., M.D.: Randolph is an internationally renowned expert in the field of bio-identical hormone replacement. He is a board-certified obstetrician and gynecologist who practiced as a compounding pharmacist. He is the co-founder of the Natural Hormone Institute, a Diplomat of the American Board of Holistic Medicine, and a member of the International Academy of Compounding Pharmacists. He coauthored ''From Belly Fat to Belly Flat, From Hormone Hell to Hormone Well,'' and ''In the Mood Again'' (Simon & Schuster 2010).

About Genie James, M.M.Sc.: Genie is nationally acknowledged as a change-agent for improved women's health. She is the co-founder and executive director of the Natural Hormone Institute. She coauthored ''From Belly Fat to Belly Flat, From Hormone Hell to Hormone Well,'' and ''In the Mood Again'' (Simon & Schuster 2010).

Media Contact
Nanette Noffsinger
Burke Hollow Media
(615) 776-4230
nanette(at)burkehollowmedia(dot)com

###

Read the full story at http://www.prweb.com/releases/Breast_Cancer/Synthetic_Hormones/prweb2777324.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Transcept Announces Plans to Reduce Expenses by Decreasing Staff Following Recent Completion of Purdue U.S. License and Collaboration Agreement
2. Statement from the American College of Surgeons Regarding Recent Comments from President Obama
3. Noted Vertebroplasty Expert Cites Concerns About Recently Published Study
4. Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments
5. The Obesity Society Position on Recent Criticism of Surgeon General Nominee Regina Benjamin
6. Arizona Pain Specialists Contend Recent Vertebroplasty Studies are Misleading: Studies Actually Show it is Effective at Reducing Pain
7. ReGen Biologics Clarifies Recent Press about the Menaflex Device
8. Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments
9. PracticeMatch Releases Results of Recent State of the Industry Survey of Physician Recruiters
10. Recently Released Data from the National Survey of Childrens Health Reports That Autism Now Affects 1% of Children and is More Common Than Childrens Cancer, Diabetes, and AIDS Combined.
11. American Association for Homecare Sets the Record Straight About Recent Home Medical Equipment Issues in the News
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Recent Article Reveals Medical Ghostwriting Suppressed Links Between Synthetic Hormones and Breast Cancer
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 ... Tomorrow,s Leaders Scholarship is any indication, the future is ... online at www.diabetesscholars.org by the Diabetes Scholars ... in the way of academic and community service excellence. ... program since 2012, and continues to advocate for people ...
Breaking Medicine Technology: